Skip to main content
Top
Published in: Arthritis Research & Therapy 6/2014

Open Access 01-12-2014 | Erratum

Erratum to: Independent associations of total and high molecular weight adiponectin with cardiometabolic risk and surrogate markers of enhanced early atherogenesis in black and white patients with rheumatoid arthritis: a cross-sectional study

Authors: Patrick H Dessein, Angela J Woodiwiss, Gavin R Norton, Linda Tsang, Ahmed Solomon

Published in: Arthritis Research & Therapy | Issue 6/2014

Login to get access

Abstract

No abstract
Literature
1.
go back to reference Dessein H, Woodiwiss A, Norton GR, Tsang L, Solomon A: Independent associations of total and high molecular weight adiponectin with cardiometabolic risk and surrogate markers of enhanced early atherogenesis in black and white patients with rheumatoid arthritis: a cross-sectional study. Arthritis Res Ther. 2013, 15: R128-10.1186/ar4308.PubMedCentralCrossRefPubMed Dessein H, Woodiwiss A, Norton GR, Tsang L, Solomon A: Independent associations of total and high molecular weight adiponectin with cardiometabolic risk and surrogate markers of enhanced early atherogenesis in black and white patients with rheumatoid arthritis: a cross-sectional study. Arthritis Res Ther. 2013, 15: R128-10.1186/ar4308.PubMedCentralCrossRefPubMed
Metadata
Title
Erratum to: Independent associations of total and high molecular weight adiponectin with cardiometabolic risk and surrogate markers of enhanced early atherogenesis in black and white patients with rheumatoid arthritis: a cross-sectional study
Authors
Patrick H Dessein
Angela J Woodiwiss
Gavin R Norton
Linda Tsang
Ahmed Solomon
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Arthritis Research & Therapy / Issue 6/2014
Electronic ISSN: 1478-6362
DOI
https://doi.org/10.1186/s13075-014-0503-3

Other articles of this Issue 6/2014

Arthritis Research & Therapy 6/2014 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.